SCHEMBL7123083

SCHEMBL7123083

O=C(Nc1ccc(Cl)cc1)c1ccccc1NS(=O)(=O)c1ccc(F)c(F)c1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.67
KMT2A Q03164 7/20 0.67
KDM4E B2RXH2 3/20 0.67
GPR27 Q9NS67 6/20 0.60
SLC10A2 Q12908 2/20 0.60
SLC10A1 Q14973 2/20 0.60
SLC10A6 Q3KNW5 2/20 0.60
LMNA P02545 2/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
BDKRB1 P46663 2/20 0.59
ALDH1A1 P00352 3/20 0.58
POLB P06746 1/20 0.56
MAPT P10636 1/20 0.56
CRHBP P24387 1/20 0.56
CRHR2 Q13324 1/20 0.56
USP2 O75604 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
AVPR2 P30518 1/20 0.54
HSD17B10 Q99714 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7126135 0.87 MEN1 (0.69) MEN1KMT2AKDM4EGPR27SLC10A2
SCHEMBL14267570 0.83 MEN1 (0.73) MEN1KMT2AKDM4EGPR27SLC10A2
SCHEMBL7128109 0.83 MEN1 (0.64) MEN1KMT2AKDM4EGPR27SLC10A2
SCHEMBL7125249 0.82 HTT (0.56) MEN1KMT2AKDM4ESLC10A2SLC10A1
SCHEMBL6861391 0.82 MEN1 (0.72) MEN1KMT2AKDM4EGPR27SLC10A2
SCHEMBL7120286 0.82 SLC20A2 (0.74) MEN1KMT2AKDM4EGPR27SLC10A2
SCHEMBL5119195 0.81 MEN1 (0.67) MEN1KMT2AKDM4EGPR27SLC10A2
SCHEMBL5124321 0.81 MEN1 (0.66) MEN1KMT2AKDM4EGPR27SLC10A2
SCHEMBL5125023 0.81 MEN1 (0.69) MEN1KMT2AKDM4EGPR27SLC10A2
SCHEMBL20560717 0.80 SLC10A2 (0.70) MEN1KMT2AKDM4EGPR27SLC10A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030216449-A1 Phosphate transport inhibitors SMITHKLINE BEECHAM CORPORATION 2003-11-20 US claimed
WO-2001087294-A1 PHOSPHATE TRANSPORT INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-11-22 WO claimed
US-20030216449-A1 Phosphate transport inhibitors SMITHKLINE BEECHAM CORPORATION 2003-11-20 US disclosed
WO-2001087294-A1 PHOSPHATE TRANSPORT INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-11-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216449-A1 Phosphate transport inhibitors SLC34A2, SLC34A1, SLC34A3 MEN1 3779/4885KMT2A 4033/4885KDM4E 2954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.